- Home
- HCAT vs TERN Comparison
HCAT vs TERN Comparison
Compare HCAT & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCAT
- TERN
- Stock Information
- Founded
- HCAT 2008
- TERN 2017
- Country
- HCAT United States
- TERN United States
- Employees
- HCAT N/A
- TERN N/A
- Industry
- HCAT Computer Software: Programming Data Processing
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- HCAT Technology
- TERN Health Care
- Exchange
- HCAT Nasdaq
- TERN Nasdaq
- Market Cap
- HCAT 259.8M
- TERN 263.8M
- IPO Year
- HCAT 2019
- TERN 2021
- Fundamental
- Price
- HCAT $3.80
- TERN $3.11
- Analyst Decision
- HCAT Buy
- TERN Buy
- Analyst Count
- HCAT 11
- TERN 5
- Target Price
- HCAT $8.00
- TERN $15.63
- AVG Volume (30 Days)
- HCAT 521.3K
- TERN 738.7K
- Earning Date
- HCAT 05-07-2025
- TERN 05-08-2025
- Dividend Yield
- HCAT N/A
- TERN N/A
- EPS Growth
- HCAT N/A
- TERN N/A
- EPS
- HCAT N/A
- TERN N/A
- Revenue
- HCAT $311,274,000.00
- TERN N/A
- Revenue This Year
- HCAT $11.21
- TERN N/A
- Revenue Next Year
- HCAT $9.73
- TERN N/A
- P/E Ratio
- HCAT N/A
- TERN N/A
- Revenue Growth
- HCAT 4.88
- TERN N/A
- 52 Week Low
- HCAT $3.49
- TERN $1.87
- 52 Week High
- HCAT $9.24
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- HCAT 44.78
- TERN 54.76
- Support Level
- HCAT $3.49
- TERN $2.84
- Resistance Level
- HCAT $3.83
- TERN $3.17
- Average True Range (ATR)
- HCAT 0.22
- TERN 0.19
- MACD
- HCAT -0.02
- TERN 0.01
- Stochastic Oscillator
- HCAT 24.80
- TERN 73.98
About HCAT Health Catalyst Inc
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.